Choosing the Appropriate COVID-19 Monoclonal Antibody Therapies and Antiviral Therapeutics and Accessing the new Antiviral Medications

The Indiana Department of Health has released a new resource related to the multiple COVID-19 treatments with key recommendations for therapies including the new antiviral medications that can be taken orally at a person home. Not all treatments can be therapeutic for everyone and using the guide will help providers in identifying appropriate treatment.

The use of the new “at Home” antiviral medications have a very limited supply, and a prescription does not guarantee the medication will be available. A residents healthcare provider might recommend one of the new antiviral medications listed in the guideline to help relieve symptoms during a COVID-19 infections.  The new Guideline, a listing of Indiana locations with a limited supply of the antiviral medications and other information can be obtained at the following:

• Key Recommendations for Monoclonal Antibody Therapies
• Key Recommendations for Antiviral Therapies
• Therapeutic IHAN 1-3-22.pdf
• Novel Coronavirus (COVID-19): COVID-19 Treatment Information
• FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov)
• FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov)